Key Highlights: Implications: The new cGMP/US FDA/EU-compliant suite at Gland’s Visakhapatnam JNPC site, adding ~1,400 kg/year of sterile API capacity, should help both companies capture m...
Key Highlights: Implications: EssilorLuxottica is using Essilor Stellest to move India’s pediatric myopia market from simple correction to active control, position...
